Drug Type Small molecule drug |
Synonyms Eptazocine hydrobromide (JAN), Sedapain |
Mechanism κ opioid receptor agonists(Kappa opioid receptor agonists), μ opioid receptor antagonists(Mu opioid receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (12 Jan 1987), |
Regulation- |
Molecular FormulaC15H21NO |
InChIKeyZOWQTJXNFTWSCS-JOPIAHFSSA-N |
CAS Registry72522-13-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01879 | Eptazocine Hydrobromide | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Cancer Pain | JP | 12 Jan 1987 | |
Pain, Postoperative | JP | 12 Jan 1987 |